1007P cfDNA and ctDNA variations are predictive of disease progression to conventional transarterial chemoembolization (cTACE) in patients with hepatocellular carcinoma (HCC)

Autor: Sefrioui, D., Verdier, V., Savoye-Collet, C., Beaussire, L., Ghomadi, S., Gangloff, A., Goria, O., Riachi, G., Montialoux, H., Schwarz, L., Tuech, J-J., Frebourg, T., Michel, P., Vasseur, N. Sarafan, Di Fiore, F.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S698-S698
Databáze: ScienceDirect